SHENZHEN GENOIMMUNE MEDICAL INSTITUTE
Shenzhen Genoimmune Medical Institute provides contracted research & technical services for individually cell-based immunotherapy.
SHENZHEN GENOIMMUNE MEDICAL INSTITUTE
Industry:
Biotechnology Health Care Medical
Founded:
2015-01-01
Address:
Shenzhen, Guangdong, China
Country:
China
Website Url:
http://www.szgimi.org
Status:
Active
Contact:
+86 0 755 867 2 5195
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Font Awesome Apache Mobile Non Scaleable Content Euro DigiCert SSL Pound Sterling Japanese Yen Encryption Everywhere
Official Site Inspections
http://www.szgimi.org
- Host name: 121.40.50.12
- IP address: 121.40.50.12
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Shenzhen Genoimmune Medical Institute"
Shenzhen Genoimmune Medical Institute - szgimi.org
Our mission is to develop affordable cell- and gene-based therapies with better efficacy to help patients fight against cancers and achieve long-term remission.See details»
Shenzhen Genoimmune Medical Institute - szgimi.org
ShenZhen Geno-immune Medical Institute (GIMI) was established in 2015 and funded by the Municipal Government of Shenzhen. GIMI faculty and team focus on translational research of …See details»
Bsports网页版(官方)官方网站IOS/安卓通用版/手机APP
Our immune therapy portfolio* is designed to recognize and kill highly multiple tumor targets. With more than 20 years of developing different immune therapies to treat blood cancers and solid …See details»
Shenzhen Genoimmune Medical Institute - Crunchbase
Organization. Shenzhen Genoimmune Medical Institute . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. ... Contact Email …See details»
Shenzhen Geno-Immune Medical Institute - CMOCRO
Shenzhen Geno-Immune Medical Institute\'s key function and goal is to provide contracted research & technical services for individually cell-based immunotherapy. The research team …See details»
Shenzhen Geno-Immune Medical Institute | VentureRadar
MIGAL Galilee Research Institute Israel Research Institute MIGAL is an independent research organization whose mission is to promote and conduct applied research to benefit private and …See details»
Universal 4SCAR7U Targeting CD7-positive Malignancies - ICH GCP
Aug 8, 2023 The purpose of this clinical trial is to assess the feasibility, safety and efficacy of universal CAR T cells based on 4SCAR7U design against CD7-positive hematological …See details»
Universal CAR-T Cells Targeting AML - ICH GCP
Aug 8, 2023 Acute myeloid leukemia (AML) is a malignant disease characterized by the rapid growth of myeloblasts that grow in the bone marrow and interferes with the generation of …See details»
深圳市免疫基因治疗研究院 - szgimi.org
我们的免疫治疗组合旨在识别和杀死高度多个肿瘤靶点。gimi开发了20多年的不同免疫疗法来治疗血液肿瘤和实体瘤，拥有广泛的car-t疗法、工程免疫效应细胞（eie）疗法和树突状细胞（dc）疫苗的抗原靶点组合。See details»
张隆基-电子科技大学医学院 - UESTC
教师简介张隆基（Lung-Ji Chang）毕业于美国爱荷华大学，电子科技大学医学院教授。发表国际权SCI 论文130篇，200多篇国际期刊和国际会议论文，发明专利25项，出版书刊10余本，参 …See details»
Antigen-specific T cells CAR-T/CTL and DCvac in T-Cell Acute
Feb 21, 2022 Email: [email protected]; Study Locations. China. Guangdong. Shenzhen, Guangdong, China, 518000. Recruiting; Shenzhen Geno-immune Medical Institute; Contact: …See details»
4SCAR2.0: a multi-CAR-T therapy regimen for the treatment of
Mar 17, 2021 7 Shenzhen Geno-Immune Medical Institute, 518000, Shenzhen, China. [email protected]. 8 University of Electronic Science and Technology of China, 611731, Chengdu, …See details»
Shenzhen Genoimmune Medical Institute - szgimi.org
Email: [email protected]; [email protected] WeChat ID: chinayuva Language: English & Chinese Expertise/Experiences： Over 30 years in cell and molecular biology, virology, …See details»
Transduction of modified factor VIII gene improves lentiviral gene ...
Electronic address: [email protected]. PMID: 34774524 PMCID: PMC8649223 DOI: 10.1016/j.jbc.2021.101397 Abstract Hemophilia A (HA) is a bleeding disorder caused by …See details»
Universal CAR-T Cells Targeting Multiple Myeloma - ICH GCP
Aug 8, 2023 The aim of this study is to assess the feasibility, safety and efficacy of universal CAR T cells targeting multiple myeloma. Another goal of the study is to learn more about the …See details»
YGOrganization | Yu-Gi-Oh! news that ends misinformation
2 days ago YGOrganization is the world’s most reliable information source for all Yu-Gi-Oh! news and content.See details»
- 深圳市免疫基因治疗研究院 - szgimi.org
研究院开展新冠病毒 delta 变异毒株细胞免疫功能研究. 随着变异体 B.1.617.2 Delta 毒株出现，在现有疫苗上保护性已经降低 ，后续还有更多的新突变株陆续出现。 可以预见 “ 逃避免疫 ” 会 …See details»
Home | SGI Canada
The Soka Gakkai International (SGI) is a worldwide organization dedicated to peace, culture and education based on the humanistic philosophy of Nichiren Buddhism. There are 12 million SGI …See details»
深圳市免疫基因治疗研究院 - szgimi.org
研究院主要研究方向是针对癌症的car-t免疫细胞治疗及针对基因相关疾病的治疗See details»
Direct intravenous injection of ivlv-X1 lentiviral vector in SCID, X ...
Jul 3, 2017 Email: [email protected]; Guangxi. Guilin, Guangxi, China. Recruiting; Guilin Hospital of Chinese Traditional and Western Medicine; Contact: Qiyong Zhu, MD; Phone Number: +86 …See details»